Suppr超能文献

来自普通人群样本中不同形式慢性气道阻塞的病程及预后。

The course and prognosis of different forms of chronic airways obstruction in a sample from the general population.

作者信息

Burrows B, Bloom J W, Traver G A, Cline M G

机构信息

Division of Respiratory Sciences, University of Arizona College of Medicine, Tucson 85724.

出版信息

N Engl J Med. 1987 Nov 19;317(21):1309-14. doi: 10.1056/NEJM198711193172103.

Abstract

We examined the course and prognosis in subjects selected from the general population who had chronic airflow obstruction at the time of their enrollment in a longitudinal epidemiologic study. Mortality and the rate of change in lung function were analyzed in relation to the initial clinical characteristics of the subjects. Twenty-seven subjects with symptoms and signs of asthma (Group I) had a higher survival rate and a much lower rate of decline in pulmonary function than the 45 subjects in Group III, whose clinical characteristics were more compatible with an emphysematous form of chronic obstructive pulmonary disease (COPD). The 10-year mortality among subjects in Group III (non-atopic smokers without a history of asthma) was close to 60 percent, whereas it was only 15 percent in Group I (atopic subjects or nonsmokers with known asthma). The mean overall rate of decline in forced expiratory volume in one second was 70 ml per year in Group III but less than 5 ml per year in Group I. Forty-five patients (Group II) who did not clearly fit into either Group I or III had intermediate values for survival and decline in pulmonary function. Previous data on mortality from COPD and the rate of progression of the condition, although compatible with our findings in patients who had an emphysematous form of disease, are not applicable to those with an asthmatic-bronchitic form. Better control of the progression of asthmatic bronchitis with therapy may explain its more favorable prognosis.

摘要

我们对在一项纵向流行病学研究入组时患有慢性气流阻塞的普通人群中选取的受试者的病程和预后进行了研究。根据受试者的初始临床特征分析了死亡率和肺功能变化率。27名有哮喘症状和体征的受试者(第一组)的生存率较高,肺功能下降率远低于第三组的45名受试者,第三组受试者的临床特征更符合肺气肿型慢性阻塞性肺疾病(COPD)。第三组(无特应性的吸烟者且无哮喘病史)受试者的10年死亡率接近60%,而第一组(有特应性的受试者或已知患有哮喘的非吸烟者)仅为15%。第三组一秒用力呼气容积的平均总体下降率为每年70毫升,而第一组每年不到5毫升。45名患者(第二组)既不属于第一组也不属于第三组,其生存率和肺功能下降情况处于中间值。先前关于COPD死亡率和病情进展率的数据,虽然与我们在患有肺气肿型疾病患者中的发现相符,但不适用于患有哮喘性支气管炎型的患者。通过治疗更好地控制哮喘性支气管炎的进展可能解释了其更有利的预后。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验